206 related articles for article (PubMed ID: 28611349)
21. Clinical significance of circulating tumor cells, including cancer stem-like cells, in peripheral blood for recurrence and prognosis in patients with Dukes' stage B and C colorectal cancer.
Iinuma H; Watanabe T; Mimori K; Adachi M; Hayashi N; Tamura J; Matsuda K; Fukushima R; Okinaga K; Sasako M; Mori M
J Clin Oncol; 2011 Apr; 29(12):1547-55. PubMed ID: 21422427
[TBL] [Abstract][Full Text] [Related]
22. The high expression of long non-coding RNA PANDAR indicates a poor prognosis for colorectal cancer and promotes metastasis by EMT pathway.
Lu M; Liu Z; Li B; Wang G; Li D; Zhu Y
J Cancer Res Clin Oncol; 2017 Jan; 143(1):71-81. PubMed ID: 27629879
[TBL] [Abstract][Full Text] [Related]
23. The association between neutropenia and prognosis in stage III colorectal cancer patients receiving adjuvant chemotherapy.
Sunaga T; Suzuki S; Kogo M; Kurihara T; Kaji S; Koike N; Harada N; Suzuki M; Kiuchi Y
Eur J Cancer Care (Engl); 2014 May; 23(3):394-400. PubMed ID: 24033646
[TBL] [Abstract][Full Text] [Related]
24. Determinants of survival after liver resection for metastatic colorectal carcinoma.
Parau A; Todor N; Vlad L
J BUON; 2015; 20(1):68-77. PubMed ID: 25778299
[TBL] [Abstract][Full Text] [Related]
25. Prognostic significance of matrix metalloproteinase-9 (MMP-9) in stage II colorectal carcinoma.
Buhmeida A; Bendardaf R; Hilska M; Collan Y; Laato M; Syrjänen S; Syrjänen K; Pyrhönen S
J Gastrointest Cancer; 2009; 40(3-4):91-7. PubMed ID: 19921474
[TBL] [Abstract][Full Text] [Related]
26. Is perineural invasion (PN) a determinant of disease free survival in early stage colorectal cancer?
Ozturk MA; Dane F; Karagoz S; Tural D; Selcukbiricik F; Demirelli F; Buyukunal E; Ozguroglu M; Turna H; Erdamar S; Celikel CA; Bozkurtlar EB; Yumuk PF; Mandel NM; Turhal NS; Serdengecti S
Hepatogastroenterology; 2015; 62(137):59-64. PubMed ID: 25911868
[TBL] [Abstract][Full Text] [Related]
27. Neutrophils to lymphocytes ratio as a useful prognosticator for stage II colorectal cancer patients.
Dimitriou N; Felekouras E; Karavokyros I; Alexandrou A; Pikoulis E; Griniatsos J
BMC Cancer; 2018 Dec; 18(1):1202. PubMed ID: 30509242
[TBL] [Abstract][Full Text] [Related]
28. Karyopherin α-2 is a reliable marker for identification of patients with high-risk stage II colorectal cancer.
Jeong D; Kim H; Ban S; Oh S; Ji S; Kim D; Ahn TS; Kim HJ; Bae SB; Kwon HY; Im J; Lee MS; Cho HD; Kim CJ; Baek MJ
J Cancer Res Clin Oncol; 2017 Dec; 143(12):2493-2503. PubMed ID: 28875407
[TBL] [Abstract][Full Text] [Related]
29. Increased expression of Slug and Vimentin as novel predictive biomarkers for lymph node metastasis and poor prognosis in colorectal cancer.
Toiyama Y; Yasuda H; Saigusa S; Tanaka K; Inoue Y; Goel A; Kusunoki M
Carcinogenesis; 2013 Nov; 34(11):2548-57. PubMed ID: 24001454
[TBL] [Abstract][Full Text] [Related]
30. Nuclear orphan receptor NR4A2 confers chemoresistance and predicts unfavorable prognosis of colorectal carcinoma patients who received postoperative chemotherapy.
Han Y; Cai H; Ma L; Ding Y; Tan X; Liu Y; Su T; Yu Y; Chang W; Zhang H; Fu C; Cao G
Eur J Cancer; 2013 Nov; 49(16):3420-30. PubMed ID: 23809767
[TBL] [Abstract][Full Text] [Related]
31. Podoplanin expression identified in stromal fibroblasts as a favorable prognostic marker in patients with colorectal carcinoma.
Yamanashi T; Nakanishi Y; Fujii G; Akishima-Fukasawa Y; Moriya Y; Kanai Y; Watanabe M; Hirohashi S
Oncology; 2009; 77(1):53-62. PubMed ID: 19556810
[TBL] [Abstract][Full Text] [Related]
32. A high preoperative carbohydrate antigen 19-9 level is a risk factor for recurrence in stage II colorectal cancer.
Nozawa H; Ishihara S; Kawai K; Hata K; Kiyomatsu T; Tanaka T; Nishikawa T; Otani K; Yasuda K; Sasaki K; Murono K; Watanabe T
Acta Oncol; 2017 May; 56(5):634-638. PubMed ID: 27885879
[TBL] [Abstract][Full Text] [Related]
33. Stratifying risk of recurrence in stage II colorectal cancer using deregulated stromal and epithelial microRNAs.
Bullock MD; Pickard K; Mitter R; Sayan AE; Primrose JN; Ivan C; Calin GA; Thomas GJ; Packham GK; Mirnezami AH
Oncotarget; 2015 Mar; 6(9):7262-79. PubMed ID: 25788261
[TBL] [Abstract][Full Text] [Related]
34. T-cell leukemia/lymphoma-1A predicts the clinical outcome for patients with stage II/III colorectal cancer.
Li H; Yan X; Liu L; Huang L; Yin M; Pan C; Zhang P; Qin H
Biomed Pharmacother; 2017 Apr; 88():924-930. PubMed ID: 28178623
[TBL] [Abstract][Full Text] [Related]
35. Prognostic significance of multiple molecular markers for patients with stage II colorectal cancer undergoing curative resection.
Uen YH; Lin SR; Wu DC; Su YC; Wu JY; Cheng TL; Chi CW; Wang JY
Ann Surg; 2007 Dec; 246(6):1040-6. PubMed ID: 18043108
[TBL] [Abstract][Full Text] [Related]
36. Prognostic value of low CDX2 expression in colorectal cancers with a high stromal content - a short report.
Sandberg TP; Sweere I; van Pelt GW; Putter H; Vermeulen L; Kuppen PJ; Tollenaar RAEM; Mesker WE
Cell Oncol (Dordr); 2019 Jun; 42(3):397-403. PubMed ID: 30847807
[TBL] [Abstract][Full Text] [Related]
37. Impact of CDX2 expression status on the survival of patients after curative resection for colorectal cancer liver metastasis.
Shigematsu Y; Inamura K; Yamamoto N; Mise Y; Saiura A; Ishikawa Y; Takahashi S; Kanda H
BMC Cancer; 2018 Oct; 18(1):980. PubMed ID: 30326864
[TBL] [Abstract][Full Text] [Related]
38. Loss of E-cadherin expression predicts disease recurrence and shorter survival in colorectal carcinoma.
Elzagheid A; Buhmeida A; Laato M; El-Faitori O; Syrjänen K; Collan Y; Pyrhönen S
APMIS; 2012 Jul; 120(7):539-48. PubMed ID: 22716209
[TBL] [Abstract][Full Text] [Related]
39. Periostin expression in intra-tumoral stromal cells is prognostic and predictive for colorectal carcinoma via creating a cancer-supportive niche.
Xu X; Chang W; Yuan J; Han X; Tan X; Ding Y; Luo Y; Cai H; Liu Y; Gao X; Liu Q; Yu Y; Du Y; Wang H; Ma L; Wang J; Chen K; Ding Y; Fu C; Cao G
Oncotarget; 2016 Jan; 7(1):798-813. PubMed ID: 26556874
[TBL] [Abstract][Full Text] [Related]
40. Clinical significance of perineural invasion in stages II and III colorectal cancer.
Zhou Y; Wang H; Gong H; Cao M; Zhang G; Wang Y
Pathol Res Pract; 2015 Nov; 211(11):839-44. PubMed ID: 26429129
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
